Panel GR-NEG URN CMB 74 CNV ID

Ended Awarded Last action

Contract number
W81K0221F0162
Awardee
Awarding agency
Obligated
$117,516

Award facts

Contract value 100% obligated
$117,515.84 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
1060 Gaffney Rd #6600k, Fort Wainwright, AK 99703, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00010 · Gram NEG urine combo 90, part # C48640 MOD P00010 release FY25 funds $29,563
Exercise an Option P00009 · Gram NEG urine combo 90, part # C48640 MOD P00009 exercise option IV 10/01/2024-09/30/2025 $0
Funding Only Action P00008 · Gram NEG urine combo 90, part # C48640 MOD P00008 release FY24 funds $29,563
Exercise an Option P00007 · Gram NEG urine combo 90, part # C48640 MOD P00007 exercise option 3 10/01/2023-9/30/2024 $0
Supplemental Agreement for work within scope P00006 · Gram NEG urine combo 90, part # C48640 MOD P00006, deob clins 1004, 1006 -$736
Funding Only Action P00005 · Cost per test reagents - microbiology analyzer (BACH), FY23 funds available and change dodaac to HT0777. $29,563
Exercise an Option P00004 · Gram NEG urine combo 90, part # C48640 - EX option 2 $0
Terminate for Convenience P00003 · Gram NEG urine combo 90 - decrease clins 0004-0007 -$3,173
Supplemental Agreement for work within scope P00002 · Gram NEG urine combo 90 - FY 22 funding $29,563
Exercise an Option P00001 $0
Original award $3,173
Show all 11

About this award

Beckman Coulter, Inc., a subsidiary of Danaher Corporation, was awarded a delivery order valued at $117,515.84 by the Defense Health Agency for a gram-negative urine combo panel (Part # C48640) to support laboratory operations at Fort Wainwright, Alaska. This firm fixed-price delivery order, issued on July 28, 2021, with completion targeted for September 30, 2025, operates under the Critical Analyzers, Laboratory (FSS-66-III) Federal Supply Schedule. The award carries no set-aside designation, indicating competitive procurement in the open federal market.

Beckman Coulter's substantial presence in federal healthcare diagnostics is evidenced by its extensive portfolio of contracts with the Veterans Health Administration and Defense Health Agency, which collectively provides automated laboratory instrumentation, reagents, and cost-per-reportable-result solutions across multiple diagnostic testing domains including urinalysis, hematology, chemistry, and immunochemistry. The company maintains multiple indefinite delivery vehicles with the Defense Health Agency, including an $812,625 contract for urine analysis testing services and a $3.683 million contract for specimen processing instrumentation, positioning it as a critical supplier of diagnostic technologies essential to federal military healthcare delivery.

Quick answers

Who was awarded contract W81K0221F0162?

W81K0221F0162 was awarded to Beckman Coulter, Inc. by Medical Command (Department of the Army) on July 28, 2021.

How much is contract W81K0221F0162 worth?

The government has obligated $117,516 on W81K0221F0162.

Which agency awarded contract W81K0221F0162?

Medical Command (Department of the Army) awarded W81K0221F0162, with funding from Defense Health Agency (Department of Defense).

Is contract W81K0221F0162 an order under another contract?

Yes. W81K0221F0162 is a delivery order under V797D70260, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).

Was contract W81K0221F0162 competed?

The extent of competition for W81K0221F0162 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award